| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| CPC534B |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
100 µg |
Please Inquire |
 |
BUY
|
| CPC534A |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC535B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC535A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| VVV00311A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
100 µg |
$475.00
|
|
BUY
|
| VVV00311B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00312B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV00312A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
100 µg |
$475.00
|
|
BUY
|
| VVV00315A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
100 µg |
$475.00
|
|
BUY
|
| VVV00315B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00316A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$475.00
|
|
BUY
|
| VVV00316B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$1,715.00
|
|
BUY
|
| VVV00313B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00313A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
100 µg |
$475.00
|
|
BUY
|
| VVV00314B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV00314A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
100 µg |
$475.00
|
|
BUY
|
| CPC519B |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC519A |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| DVV00336B |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00336A |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
100 µg |
$475.00
|
|
BUY
|
| DVV00503A |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
100 µg |
$405.00
|
|
BUY
|
| DVV00503B |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
1.0 mg |
$1,485.00
|
|
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
